SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-19-000022
Filing Date
2019-02-14
Accepted
2019-02-14 16:20:36
Documents
2
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_155017922301827.html 5  
1 FORM 5 wf-form5_155017922301827.xml 5 5963
2 STAPLE POA ex-24.htm EX-24 3115
  Complete submission text file 0001005201-19-000022.txt   10535
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 863 C MITTEN ROAD BURLINGAME CA 94010
Business Address
STAPLE PETER D (Reporting) CIK: 0001271088 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-13111 | Film No.: 19606691